Multi_CycGT: A Deep Learning-Based Multimodal Model for Predicting the Membrane Permeability of Cyclic Peptides.

Journal: Journal of medicinal chemistry
Published Date:

Abstract

Cyclic peptides are gaining attention for their strong binding affinity, low toxicity, and ability to target "undruggable" proteins; however, their therapeutic potential against intracellular targets is constrained by their limited membrane permeability, and researchers need much time and money to test this property in the laboratory. Herein, we propose an innovative multimodal model called Multi_CycGT, which combines a graph convolutional network (GCN) and a transformer to extract one- and two-dimensional features for predicting cyclic peptide permeability. The extensive benchmarking experiments show that our Multi_CycGT model can attain state-of-the-art performance, with an average accuracy of 0.8206 and an area under the curve of 0.8650, and demonstrates satisfactory generalization ability on several external data sets. To the best of our knowledge, it is the first deep learning-based attempt to predict the membrane permeability of cyclic peptides, which is beneficial in accelerating the design of cyclic peptide active drugs in medicinal chemistry and chemical biology applications.

Authors

  • Lujing Cao
    College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, P. R. China.
  • Zhenyu Xu
    Department of Urology, The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine: Traditional Chinese Medicine Hospital of Kunshan, Kunshan, China.
  • Tianfeng Shang
    AI Department, Shanghai Highslab Therapeutics, Inc., Shanghai 201203, China.
  • Chengyun Zhang
    Artificial Intelligent Aided Drug Discovery Lab, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.
  • Xinyi Wu
    Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, PR China.
  • Yejian Wu
    Artificial Intelligence Aided Drug Discovery Institute, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China. hduan@zjut.edu.cn.
  • Silong Zhai
    School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
  • Zhajun Zhan
    College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, P. R. China.
  • Hongliang Duan
    Artificial Intelligent Aided Drug Discovery Lab, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.